CF Industries director granted 1,390 company shares

CF Industries Holdings director Susan A. Ellerbusch received a stock award as part of her compensation.

Rhea-AI Filing Summary

CF Industries Holdings director Susan A. Ellerbusch received a stock award as part of her compensation. On April 28, 2026, she acquired 1,390 shares of CF Industries common stock in a grant labeled "grant, award, or other acquisition" at a stated price of $0.00 per share. Following this award, she directly holds 7,323 common shares, reflecting her ongoing equity stake in the company rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 1,390 shares

Grant/Award 1 txn

Insider Ellerbusch Susan A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share	1,390	$0.00	$0.00

Holdings After Transaction: Common Stock, par value $0.01 per share — 7,323 shares (Direct)

Key Figures

Shares granted: 1,390 shares Grant price: $0.00 per share Shares held after: 7,323 shares +1 more

4 metrics

Shares granted 1,390 shares Non-derivative stock award on April 28, 2026

Grant price $0.00 per share Stated price for 1,390-share award

Shares held after 7,323 shares Total direct common stock holdings after grant

Transaction code A Grant, award, or other acquisition of common stock

Key Terms

Grant, award, or other acquisition, Common Stock, par value $0.01 per share, non-derivative

3 terms

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Common Stock, par value $0.01 per share financial

"security_title": "Common Stock, par value $0.01 per share""

non-derivative financial

"transaction_type": "non-derivative""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CF (CF) disclose for Susan A. Ellerbusch?

CF Industries reported that director Susan A. Ellerbusch received an equity grant of 1,390 common shares. The transaction was coded as a grant, award, or other acquisition, indicating compensation-related stock rather than an open-market purchase.

How many CF (CF) shares did Susan A. Ellerbusch receive and at what price?

Susan A. Ellerbusch was granted 1,390 shares of CF Industries common stock at a stated price of $0.00 per share. This reflects a stock award, not a cash purchase, and is recorded as a non-derivative acquisition.

What are Susan A. Ellerbusch’s total CF (CF) share holdings after this Form 4?

After the April 28, 2026 transaction, Susan A. Ellerbusch directly holds 7,323 shares of CF Industries common stock. This total incorporates the 1,390-share grant reported, providing an updated view of her direct equity position in the company.

Was the CF (CF) transaction by Susan A. Ellerbusch a market buy or a stock grant?

The filing shows a stock grant coded as a “Grant, award, or other acquisition,” not a market purchase. The 1,390 shares were acquired at $0.00 per share, indicating compensation-related equity rather than a typical open-market buy.

Does Susan A. Ellerbusch’s CF (CF) transaction involve derivative securities or options?

No derivative securities are listed for this transaction. The Form 4 describes a non-derivative acquisition of 1,390 shares of common stock, and the derivativeSummary section in the data provided is empty, indicating no related options or similar instruments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/30/2026 - 05:03 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ellerbusch Susan A

(Last) (First) (Middle)

C/O CF INDUSTRIES HOLDINGS, INC.

2375 WATERVIEW DRIVE

(Street)

NORTHBROOK ILLINOIS 60062

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CF Industries Holdings, Inc. [ CF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	04/28/2026		A		1,390	A	$0	7,323	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Michael P. McGrane, by power of attorney	04/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)